Income Taxes (Tables)

12 Months Ended

Jun. 30, 2022

Income Tax Disclosure [Abstract]

Components of Future Tax Assets and Deferred Tax Liabilities

Significant components of the Company’s deferred tax assets and deferred tax liabilities are shown below:

	June 30, 2022 $			June 30, 2021 $
Deferred tax assets:
Non-capital losses carried forward		25,541			20,148
Stock-based compensation		635			155
Capital losses carried forward		18			18
Financing costs		326			326
Bonus - compensation		85			—
Scientific research and development		803			761
Scientific research and development – Investment    Tax Credits (“ITC”)		690			665
		28,098			22,073
Deferred tax liabilities:
Scientific research and development – ITC		(114	)		(110	)
		27,984			21,963
Valuation allowance		(27,984	)		(21,963	)
Net future tax assets		—			—

Schedule of Difference Between Income Tax Rate and Statutory Income Tax Rate

The differences arise from the following items:

	June 30, 2022 $			June 30, 2021 $
Tax recovery at statutory income tax rates		(4,743	)		(8,015	)
Permanent differences		802			4,506
Effect of rate differentials between jurisdictions		(345	)		(551	)
Effect of foreign exchange rates		445			(954	)
Non-capital losses acquired with Adgero		—			(4,114	)
Scientific research and development – ITC		(44	)		97
Adjustment to prior year's provision versus statutory tax returns		(2,332	)		228
Other		196			—
Change in valuation allowance		6,021			8,803
		—			—